Clinical trials to test convalescent plasma in hospital patients expanding
Two clinical trials launched in April to evaluate convalescent plasma as a treatment for patients hospitalized with COVID-19 are expanding, the National Institutes of Health announced yesterday.
The trials each expect to enroll about 1,000 hospitalized patients at academic and community-based hospitals across the country, who will be randomly assigned to receive the treatment or a placebo. Both trials anticipate results as early as this fall.
Related News Articles
Headline
A study published April 8 by the Public Library of Science’s Journal of Global Public Health found that driving while infected with COVID-19 raises the risk of…
Headline
The Senate Finance Committee Feb. 4 voted 14-13 to advance Robert F. Kennedy Jr.’s nomination for secretary of the Department of Health and Human Services. A…
Headline
Respiratory illness activity remains high across the country, according to the latest data from the Centers for Disease Control and Prevention. Seasonal flu…
Headline
The Occupational Safety and Health Administration Jan. 13 announced that it terminated efforts to establish a final COVID-19 safety standard to protect workers…
Headline
The Department of Health and Human Services Dec. 10 amended the Public Readiness and Emergency Preparedness Act declaration for COVID-19, extending liability…
Headline
AHA's latest social media toolkit for encouraging vaccination against the flu and COVID-19 provides fall-themed social media posts and graphics. Download the…